UPDATE 1-FDA approves Regeneron, Sanofi $37,000 per year eczema drug

UPDATE 1-FDA approves Regeneron, Sanofi $37,000 per year eczema drug

UPDATE 1-FDA approves Regeneron, Sanofi $37,000 per year eczema drug, The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's Dupixent for treatment of moderate to severe atopic dermatitis,... [Read More]